PRDM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.343200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.065600E-01
Normal-vs-Stage2
2.798600E-01
Normal-vs-Stage3
7.296400E-01
Normal-vs-Stage4
4.243600E-01
Stage1-vs-Stage2
6.797000E-01
Stage1-vs-Stage3
7.676600E-01
Stage1-vs-Stage4
8.466800E-01
Stage2-vs-Stage3
8.868800E-01
Stage2-vs-Stage4
8.648000E-01
Stage3-vs-Stage4
8.315000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.469200E-01
Normal-vs-AfricanAmerican
3.512800E-01
Normal-vs-Asian
1.835980E-01
Caucasian-vs-AfricanAmerican
8.139800E-01
Caucasian-vs-Asian
6.500200E-01
AfricanAmerican-vs-Asian
5.178000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.090400E-01
Normal-vs-Female
2.920800E-01
Male-vs-Female
2.500800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.820200E-01
Normal-vs-Age(41-60Yrs)
3.119600E-01
Normal-vs-Age(61-80Yrs)
2.418600E-01
Normal-vs-Age(81-100Yrs)
1.563620E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.479000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.392400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.574000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.542200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.426000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.231600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.814300E-02
Normal-vs-Daily Drinker
1.961990E-01
Normal-vs-Weekly Drinker
5.085600E-01
Normal-vs-Occasional Drinker
9.290000E-02
Normal-vs-Social Drinker
5.683200E-01
Non Drinker-vs-Daily Drinker
4.222000E-01
Non Drinker-vs-Weekly Drinker
1.351970E-01
Non Drinker-vs-Occasional Drinker
7.150400E-01
Non Drinker-vs-Social Drinker
2.923200E-01
Daily Drinker-vs-Weekly Drinker
4.542800E-01
Daily Drinker-vs-Occasional Drinker
6.863000E-01
Daily Drinker-vs-Social Drinker
5.655200E-01
Weekly Drinker-vs-Occasional Drinker
2.791800E-01
Weekly Drinker-vs-Social Drinker
9.740400E-01
Occasional Drinker-vs-Social Drinker
4.015400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.312000E-01
Normal-vs-Grade 2
1.928370E-01
Normal-vs-Grade 3
2.896400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.184200E-03
Grade 1-vs-Grade 3
4.004200E-02
Grade 1-vs-Grade 4
6.312000E-01
Grade 2-vs-Grade 3
8.771000E-01
Grade 2-vs-Grade 4
1.928370E-01
Grade 3-vs-Grade 4
2.896400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.867400E-01
Normal-vs-NonDiabetic
1.183800E-01
Diabetic-vs-NonDiabetic
1.833170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.595800E-01
Normal-vs-NoPancreatitis
2.550200E-01
Pancreatitis-vs-NoPancreatitis
1.551380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.259800E-01
Normal-vs-N1
2.145000E-01
N0-vs-N1
8.384400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.023380E-01
Normal-vs-TP53-NonMutant
6.151700E-02
TP53-Mutant-vs-TP53-NonMutant
8.569800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
